Index by author
July 01, 2021; Volume 378,Issue 1
A
Abame, Melkamu Alemu
- Open AccessTPN672: A Novel Serotonin-Dopamine Receptor Modulator for the Treatment of SchizophreniaYu Wang, Yang He, Feipu Yang, Melkamu Alemu Abame, Chunhui Wu, Yanmin Peng, Linyin Feng, Jingshan Shen, Zhen Wang and Ling HeJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 20-30; DOI: https://doi.org/10.1124/jpet.120.000414
C
Cheng, Cheng
- You have accessA p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6Henri Leinonen, Cheng Cheng, Marja Pitkänen, Christopher L. Sander, Jianye Zhang, Sama Saeid, Teemu Turunen, Alyaa Shmara, Lan Weiss, Lac Ta, Timothy Ton, Ari Koskelainen, Jesse D. Vargas, Virginia Kimonis and Krzysztof PalczewskiJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 31-41; DOI: https://doi.org/10.1124/jpet.120.000486
Chinnakkannu, Panneerselvam
- You have accessThe Caveolin-1 Scaffolding Domain Peptide Reverses Aging-Associated Deleterious Changes in Multiple OrgansDhandapani Kuppuswamy, Panneerselvam Chinnakkannu, Charles Reese and Stanley HoffmanJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 1-9; DOI: https://doi.org/10.1124/jpet.120.000424
F
Feng, Linyin
- Open AccessTPN672: A Novel Serotonin-Dopamine Receptor Modulator for the Treatment of SchizophreniaYu Wang, Yang He, Feipu Yang, Melkamu Alemu Abame, Chunhui Wu, Yanmin Peng, Linyin Feng, Jingshan Shen, Zhen Wang and Ling HeJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 20-30; DOI: https://doi.org/10.1124/jpet.120.000414
H
Han, Joo-Hui
- You have accessRosuvastatin Inhibits the Apoptosis of Platelet-Derived Growth Factor–Stimulated Vascular Smooth Muscle Cells by Inhibiting p38 via AutophagyJun-Hwan Jo, Hyun-Soo Park, Do-Hyung Lee, Joo-Hui Han, Kyung-Sun Heo and Chang-Seon MyungJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 10-19; DOI: https://doi.org/10.1124/jpet.121.000539
He, Ling
- Open AccessTPN672: A Novel Serotonin-Dopamine Receptor Modulator for the Treatment of SchizophreniaYu Wang, Yang He, Feipu Yang, Melkamu Alemu Abame, Chunhui Wu, Yanmin Peng, Linyin Feng, Jingshan Shen, Zhen Wang and Ling HeJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 20-30; DOI: https://doi.org/10.1124/jpet.120.000414
He, Yang
- Open AccessTPN672: A Novel Serotonin-Dopamine Receptor Modulator for the Treatment of SchizophreniaYu Wang, Yang He, Feipu Yang, Melkamu Alemu Abame, Chunhui Wu, Yanmin Peng, Linyin Feng, Jingshan Shen, Zhen Wang and Ling HeJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 20-30; DOI: https://doi.org/10.1124/jpet.120.000414
Heo, Kyung-Sun
- You have accessRosuvastatin Inhibits the Apoptosis of Platelet-Derived Growth Factor–Stimulated Vascular Smooth Muscle Cells by Inhibiting p38 via AutophagyJun-Hwan Jo, Hyun-Soo Park, Do-Hyung Lee, Joo-Hui Han, Kyung-Sun Heo and Chang-Seon MyungJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 10-19; DOI: https://doi.org/10.1124/jpet.121.000539
Hoffman, Stanley
- You have accessThe Caveolin-1 Scaffolding Domain Peptide Reverses Aging-Associated Deleterious Changes in Multiple OrgansDhandapani Kuppuswamy, Panneerselvam Chinnakkannu, Charles Reese and Stanley HoffmanJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 1-9; DOI: https://doi.org/10.1124/jpet.120.000424
J
Jo, Jun-Hwan
- You have accessRosuvastatin Inhibits the Apoptosis of Platelet-Derived Growth Factor–Stimulated Vascular Smooth Muscle Cells by Inhibiting p38 via AutophagyJun-Hwan Jo, Hyun-Soo Park, Do-Hyung Lee, Joo-Hui Han, Kyung-Sun Heo and Chang-Seon MyungJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 10-19; DOI: https://doi.org/10.1124/jpet.121.000539
K
Kimonis, Virginia
- You have accessA p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6Henri Leinonen, Cheng Cheng, Marja Pitkänen, Christopher L. Sander, Jianye Zhang, Sama Saeid, Teemu Turunen, Alyaa Shmara, Lan Weiss, Lac Ta, Timothy Ton, Ari Koskelainen, Jesse D. Vargas, Virginia Kimonis and Krzysztof PalczewskiJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 31-41; DOI: https://doi.org/10.1124/jpet.120.000486
Koskelainen, Ari
- You have accessA p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6Henri Leinonen, Cheng Cheng, Marja Pitkänen, Christopher L. Sander, Jianye Zhang, Sama Saeid, Teemu Turunen, Alyaa Shmara, Lan Weiss, Lac Ta, Timothy Ton, Ari Koskelainen, Jesse D. Vargas, Virginia Kimonis and Krzysztof PalczewskiJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 31-41; DOI: https://doi.org/10.1124/jpet.120.000486
Kuppuswamy, Dhandapani
- You have accessThe Caveolin-1 Scaffolding Domain Peptide Reverses Aging-Associated Deleterious Changes in Multiple OrgansDhandapani Kuppuswamy, Panneerselvam Chinnakkannu, Charles Reese and Stanley HoffmanJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 1-9; DOI: https://doi.org/10.1124/jpet.120.000424
L
Lee, Do-Hyung
- You have accessRosuvastatin Inhibits the Apoptosis of Platelet-Derived Growth Factor–Stimulated Vascular Smooth Muscle Cells by Inhibiting p38 via AutophagyJun-Hwan Jo, Hyun-Soo Park, Do-Hyung Lee, Joo-Hui Han, Kyung-Sun Heo and Chang-Seon MyungJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 10-19; DOI: https://doi.org/10.1124/jpet.121.000539
Leinonen, Henri
- You have accessA p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6Henri Leinonen, Cheng Cheng, Marja Pitkänen, Christopher L. Sander, Jianye Zhang, Sama Saeid, Teemu Turunen, Alyaa Shmara, Lan Weiss, Lac Ta, Timothy Ton, Ari Koskelainen, Jesse D. Vargas, Virginia Kimonis and Krzysztof PalczewskiJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 31-41; DOI: https://doi.org/10.1124/jpet.120.000486
M
Morris, Marilyn E.
- You have accessγ-Hydroxybutyric Acid–Ethanol Drug-Drug Interaction: Reversal of Toxicity with Monocarboxylate Transporter 1 InhibitorsVivian Rodriguez-Cruz and Marilyn E. MorrisJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 42-50; DOI: https://doi.org/10.1124/jpet.121.000566
Myung, Chang-Seon
- You have accessRosuvastatin Inhibits the Apoptosis of Platelet-Derived Growth Factor–Stimulated Vascular Smooth Muscle Cells by Inhibiting p38 via AutophagyJun-Hwan Jo, Hyun-Soo Park, Do-Hyung Lee, Joo-Hui Han, Kyung-Sun Heo and Chang-Seon MyungJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 10-19; DOI: https://doi.org/10.1124/jpet.121.000539
P
Palczewski, Krzysztof
- You have accessA p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6Henri Leinonen, Cheng Cheng, Marja Pitkänen, Christopher L. Sander, Jianye Zhang, Sama Saeid, Teemu Turunen, Alyaa Shmara, Lan Weiss, Lac Ta, Timothy Ton, Ari Koskelainen, Jesse D. Vargas, Virginia Kimonis and Krzysztof PalczewskiJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 31-41; DOI: https://doi.org/10.1124/jpet.120.000486
Park, Hyun-Soo
- You have accessRosuvastatin Inhibits the Apoptosis of Platelet-Derived Growth Factor–Stimulated Vascular Smooth Muscle Cells by Inhibiting p38 via AutophagyJun-Hwan Jo, Hyun-Soo Park, Do-Hyung Lee, Joo-Hui Han, Kyung-Sun Heo and Chang-Seon MyungJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 10-19; DOI: https://doi.org/10.1124/jpet.121.000539
Peng, Yanmin
- Open AccessTPN672: A Novel Serotonin-Dopamine Receptor Modulator for the Treatment of SchizophreniaYu Wang, Yang He, Feipu Yang, Melkamu Alemu Abame, Chunhui Wu, Yanmin Peng, Linyin Feng, Jingshan Shen, Zhen Wang and Ling HeJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 20-30; DOI: https://doi.org/10.1124/jpet.120.000414
Pitkänen, Marja
- You have accessA p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6Henri Leinonen, Cheng Cheng, Marja Pitkänen, Christopher L. Sander, Jianye Zhang, Sama Saeid, Teemu Turunen, Alyaa Shmara, Lan Weiss, Lac Ta, Timothy Ton, Ari Koskelainen, Jesse D. Vargas, Virginia Kimonis and Krzysztof PalczewskiJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 31-41; DOI: https://doi.org/10.1124/jpet.120.000486
R
Reese, Charles
- You have accessThe Caveolin-1 Scaffolding Domain Peptide Reverses Aging-Associated Deleterious Changes in Multiple OrgansDhandapani Kuppuswamy, Panneerselvam Chinnakkannu, Charles Reese and Stanley HoffmanJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 1-9; DOI: https://doi.org/10.1124/jpet.120.000424
Rodriguez-Cruz, Vivian
- You have accessγ-Hydroxybutyric Acid–Ethanol Drug-Drug Interaction: Reversal of Toxicity with Monocarboxylate Transporter 1 InhibitorsVivian Rodriguez-Cruz and Marilyn E. MorrisJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 42-50; DOI: https://doi.org/10.1124/jpet.121.000566
S
Saeid, Sama
- You have accessA p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6Henri Leinonen, Cheng Cheng, Marja Pitkänen, Christopher L. Sander, Jianye Zhang, Sama Saeid, Teemu Turunen, Alyaa Shmara, Lan Weiss, Lac Ta, Timothy Ton, Ari Koskelainen, Jesse D. Vargas, Virginia Kimonis and Krzysztof PalczewskiJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 31-41; DOI: https://doi.org/10.1124/jpet.120.000486
Sander, Christopher L.
- You have accessA p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6Henri Leinonen, Cheng Cheng, Marja Pitkänen, Christopher L. Sander, Jianye Zhang, Sama Saeid, Teemu Turunen, Alyaa Shmara, Lan Weiss, Lac Ta, Timothy Ton, Ari Koskelainen, Jesse D. Vargas, Virginia Kimonis and Krzysztof PalczewskiJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 31-41; DOI: https://doi.org/10.1124/jpet.120.000486
Shen, Jingshan
- Open AccessTPN672: A Novel Serotonin-Dopamine Receptor Modulator for the Treatment of SchizophreniaYu Wang, Yang He, Feipu Yang, Melkamu Alemu Abame, Chunhui Wu, Yanmin Peng, Linyin Feng, Jingshan Shen, Zhen Wang and Ling HeJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 20-30; DOI: https://doi.org/10.1124/jpet.120.000414
Shmara, Alyaa
- You have accessA p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6Henri Leinonen, Cheng Cheng, Marja Pitkänen, Christopher L. Sander, Jianye Zhang, Sama Saeid, Teemu Turunen, Alyaa Shmara, Lan Weiss, Lac Ta, Timothy Ton, Ari Koskelainen, Jesse D. Vargas, Virginia Kimonis and Krzysztof PalczewskiJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 31-41; DOI: https://doi.org/10.1124/jpet.120.000486
T
Ta, Lac
- You have accessA p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6Henri Leinonen, Cheng Cheng, Marja Pitkänen, Christopher L. Sander, Jianye Zhang, Sama Saeid, Teemu Turunen, Alyaa Shmara, Lan Weiss, Lac Ta, Timothy Ton, Ari Koskelainen, Jesse D. Vargas, Virginia Kimonis and Krzysztof PalczewskiJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 31-41; DOI: https://doi.org/10.1124/jpet.120.000486
Ton, Timothy
- You have accessA p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6Henri Leinonen, Cheng Cheng, Marja Pitkänen, Christopher L. Sander, Jianye Zhang, Sama Saeid, Teemu Turunen, Alyaa Shmara, Lan Weiss, Lac Ta, Timothy Ton, Ari Koskelainen, Jesse D. Vargas, Virginia Kimonis and Krzysztof PalczewskiJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 31-41; DOI: https://doi.org/10.1124/jpet.120.000486
Turunen, Teemu
- You have accessA p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6Henri Leinonen, Cheng Cheng, Marja Pitkänen, Christopher L. Sander, Jianye Zhang, Sama Saeid, Teemu Turunen, Alyaa Shmara, Lan Weiss, Lac Ta, Timothy Ton, Ari Koskelainen, Jesse D. Vargas, Virginia Kimonis and Krzysztof PalczewskiJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 31-41; DOI: https://doi.org/10.1124/jpet.120.000486
V
Vargas, Jesse D.
- You have accessA p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6Henri Leinonen, Cheng Cheng, Marja Pitkänen, Christopher L. Sander, Jianye Zhang, Sama Saeid, Teemu Turunen, Alyaa Shmara, Lan Weiss, Lac Ta, Timothy Ton, Ari Koskelainen, Jesse D. Vargas, Virginia Kimonis and Krzysztof PalczewskiJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 31-41; DOI: https://doi.org/10.1124/jpet.120.000486
W
Wang, Yu
- Open AccessTPN672: A Novel Serotonin-Dopamine Receptor Modulator for the Treatment of SchizophreniaYu Wang, Yang He, Feipu Yang, Melkamu Alemu Abame, Chunhui Wu, Yanmin Peng, Linyin Feng, Jingshan Shen, Zhen Wang and Ling HeJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 20-30; DOI: https://doi.org/10.1124/jpet.120.000414
Wang, Zhen
- Open AccessTPN672: A Novel Serotonin-Dopamine Receptor Modulator for the Treatment of SchizophreniaYu Wang, Yang He, Feipu Yang, Melkamu Alemu Abame, Chunhui Wu, Yanmin Peng, Linyin Feng, Jingshan Shen, Zhen Wang and Ling HeJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 20-30; DOI: https://doi.org/10.1124/jpet.120.000414
Weiss, Lan
- You have accessA p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6Henri Leinonen, Cheng Cheng, Marja Pitkänen, Christopher L. Sander, Jianye Zhang, Sama Saeid, Teemu Turunen, Alyaa Shmara, Lan Weiss, Lac Ta, Timothy Ton, Ari Koskelainen, Jesse D. Vargas, Virginia Kimonis and Krzysztof PalczewskiJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 31-41; DOI: https://doi.org/10.1124/jpet.120.000486
Wu, Chunhui
- Open AccessTPN672: A Novel Serotonin-Dopamine Receptor Modulator for the Treatment of SchizophreniaYu Wang, Yang He, Feipu Yang, Melkamu Alemu Abame, Chunhui Wu, Yanmin Peng, Linyin Feng, Jingshan Shen, Zhen Wang and Ling HeJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 20-30; DOI: https://doi.org/10.1124/jpet.120.000414
Y
Yang, Feipu
- Open AccessTPN672: A Novel Serotonin-Dopamine Receptor Modulator for the Treatment of SchizophreniaYu Wang, Yang He, Feipu Yang, Melkamu Alemu Abame, Chunhui Wu, Yanmin Peng, Linyin Feng, Jingshan Shen, Zhen Wang and Ling HeJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 20-30; DOI: https://doi.org/10.1124/jpet.120.000414
Z
Zhang, Jianye
- You have accessA p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6Henri Leinonen, Cheng Cheng, Marja Pitkänen, Christopher L. Sander, Jianye Zhang, Sama Saeid, Teemu Turunen, Alyaa Shmara, Lan Weiss, Lac Ta, Timothy Ton, Ari Koskelainen, Jesse D. Vargas, Virginia Kimonis and Krzysztof PalczewskiJournal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 31-41; DOI: https://doi.org/10.1124/jpet.120.000486
In this issue
Advertisement